Your browser doesn't support javascript.
Tryptophan Metabolism 'Hub' Gene Expression Associates with Increased Inflammation and Severe Disease Outcomes in COVID-19 Infection and Inflammatory Bowel Disease.
Bustamante, Sonia; Yau, Yunki; Boys, Victoria; Chang, Jeff; Paramsothy, Sudarshan; Pudipeddi, Aviv; Leong, Rupert W; Wasinger, Valerie C.
  • Bustamante S; Bioanalytical Mass Spectrometry Facility, Mark Wainwright Analytical Centre, The University of New South Wales, Sydney, NSW 2052, Australia.
  • Yau Y; Department of Gastroenterology, Concord Repatriation General Hospital, Sydney, NSW 2139, Australia.
  • Boys V; School of Medical Sciences, Faculty of Medicine, The University of New South Wales, Sydney, NSW 2052, Australia.
  • Chang J; Department of Gastroenterology, Concord Repatriation General Hospital, Sydney, NSW 2139, Australia.
  • Paramsothy S; Department of Gastroenterology, Concord Repatriation General Hospital, Sydney, NSW 2139, Australia.
  • Pudipeddi A; Department of Gastroenterology, Concord Repatriation General Hospital, Sydney, NSW 2139, Australia.
  • Leong RW; Department of Gastroenterology, Concord Repatriation General Hospital, Sydney, NSW 2139, Australia.
  • Wasinger VC; Bioanalytical Mass Spectrometry Facility, Mark Wainwright Analytical Centre, The University of New South Wales, Sydney, NSW 2052, Australia.
Int J Mol Sci ; 23(23)2022 Nov 26.
Article in English | MEDLINE | ID: covidwho-2123706
ABSTRACT
The epithelial barrier's primary role is to protect against entry of foreign and pathogenic elements. Both COVID-19 and Inflammatory Bowel Disease (IBD) show commonalities in symptoms and treatment with sensitization of the epithelial barrier inviting an immune response. In this study we use a multi-omics strategy to identify a common signature of immune disease that may be able to predict for more severe patient outcomes. Global proteomic approaches were applied to transcriptome and proteome. Further semi- and relative- quantitative targeted mass spectrometry methods were developed to substantiate the proteomic and metabolomics changes in nasal swabs from healthy, COVID-19 (24 h and 3 weeks post infection); serums from Crohn's disease patients (scored for epithelial leak), terminal ileum tissue biopsies (patient matched inflamed and non-inflamed regions, and controls). We found that the tryptophan/kynurenine metabolism pathway is a 'hub' regulator of canonical and non-canonical transcription, macrophage release of cytokines and significant changes in the immune and metabolic status with increasing severity and disease course. Significantly modified pathways include stress response regulator EIF2 signaling (p = 1 × 10-3); energy metabolism, KYNU (p = 4 × 10-4), WARS (p = 1 × 10-7); inflammation, and IDO activity (p = 1 × 10-6). Heightened levels of PARP1, WARS and KYNU are predictive at the acute stage of infection for resilience, while in contrast, levels remained high and are predictive of persistent and more severe outcomes in COVID disease. Generation of a targeted marker profile showed these changes in immune disease underlay resolution of epithelial barrier function and have the potential to define disease trajectory and more severe patient outcomes.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Inflammatory Bowel Diseases / COVID-19 Type of study: Prognostic study Topics: Long Covid Limits: Humans Language: English Year: 2022 Document Type: Article Affiliation country: Ijms232314776

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Inflammatory Bowel Diseases / COVID-19 Type of study: Prognostic study Topics: Long Covid Limits: Humans Language: English Year: 2022 Document Type: Article Affiliation country: Ijms232314776